Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Malaria Journal
Published in: Malaria Journal 1/2012

Open Access 01-12-2012 | Review

Resistance to malaria in humans: the impact of strong, recent selection

Author: Philip W Hedrick

Published in: Malaria Journal | Issue 1/2012

Login to get access

Abstract

Malaria is one of the leading causes of death worldwide and has been suggested as the most potent type of selection in humans in recent millennia. As a result, genes involved in malaria resistance are excellent examples of recent, strong selection. In 1949, Haldane initially suggested that infectious disease could be a strong selective force in human populations. Evidence for the strong selective effect of malaria resistance includes the high frequency of a number of detrimental genetic diseases caused by the pleiotropic effects of these malaria resistance variants, many of which are “loss of function” mutants. Evidence that this selection is recent comes from the genetic dating of the age of a number of these malaria resistant alleles to less than 5,000 years before the present, generally much more recent than other human genetic variants. An approach to estimate selection coefficients from contemporary case–control data is presented. In the situations described here, selection is much greater than 1%, significantly higher than generally observed for other human genetic variation. With these selection coefficients, predictions are generated about the joint change of alleles S and C at the β-globin locus, and for α-thalassaemia haplotypes and S, variants that are unlinked but exhibit epistasis. Population genetics can be used to determine the amount and pattern of selection in the past and predict selection in the future for other malaria resistance variants as they are discovered.
Appendix
Available only for authorised users
Literature
1.
Kwiatkowski DP: How malaria has affected the human genome and what human genetics can teach us about malaria. Amer J Hum Genet. 2005, 77: 171-192. 10.1086/432519.PubMedCentralCrossRefPubMed
2.
Haldane JBS: Disease and evolution. La Ricerca Scientifica. 1949, 19: 68-76.
3.
Haldane JBS: The rate of mutation of human genes. Hereditas. 1949, 35 (S1): 267-273.CrossRef
4.
Crow JF: J. B. S. Haldane’s ideas in biology with special reference to disease and evolution. Infectious Disease and Host-Pathogen Evolution. Edited by: Dronamraju KR. 2004, Cambridge: Cambridge University Press, 11-17.CrossRef
5.
Weatherall DJ: J. B. S. Haldane and the malaria hypothesis. Infectious Disease and Host-Pathogen Evolution. Edited by: Dronamraju KR. 2004, Cambridge: Cambridge University Press, 18-36.CrossRef
6.
7.
8.
WHO: World Malaria Report. 2011, Geneva: World Health Organization
9.
Murray CJL, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, Fullman N, Lozano NM, Lozano R, Lopez AD: Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet. 2012, 379: 413-431. 10.1016/S0140-6736(12)60034-8.CrossRefPubMed
10.
11.
Liu W, Li V, Rudicell RS, Robertson JD, Keele BF, Ndjango J-B N, Sanz CM, Morgan DB, Locatelli S, Gonder MK, Kranzusch PJ, Walsh PD, Delaporte E, Mpoudi-Ngole E, Georgiev AV, Muller MN, Shaw GM, Peeters M, Sharp PM, Rayner JC, Hahn BH: Origin of the human malaria parasite Plasmodium falciparum in gorillas. Nature. 2010, 467: 420-425. 10.1038/nature09442.PubMedCentralCrossRefPubMed
12.
Rayner JC, Liu W, Peeters M, Sharp PM, Hahn BH: A plethora of Plasmodium species in wild apes: a source of human infection?. Trends Parasit. 2011, 27: 222-229. 10.1016/j.pt.2011.01.006.CrossRef
13.
Baron JM, Higgins JM, Dzik WH: A revised timeline for the origin of Plasmodium falciparum as a human pathogen. J Molec Evol. 2011, 73: 297-304. 10.1007/s00239-011-9476-x.CrossRefPubMed
14.
Flint J, Harding RM, Boyce AJ, Clegg JB: The population genetics of the haemoglobinopathies. Bailliere’s Clin Haemat. 1998, 11: 1-51. 10.1016/S0950-3536(98)80069-3.CrossRef
15.
Piel FB, Patil AP, Howes RE, Nyangiri OA, Gething PW, Williams TN, Weatherall DJ, Hay SI: Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nat Commun. 2010, 1: 104-10.1038/ncomms1104.PubMedCentralCrossRefPubMed
16.
Howes RE, Patil AP, Piel FB, Nyangiri OA, Kabaria CW, Gething PW, Zimmerman PA, Bernades C, Beall CM, Gebremedhin A, Ménard D, Williams TN, Weatherall DJ, Hay SI: The global distribution of the Duffy blood group. Nat Commun. 2011, 2: 226-CrossRef
17.
O’Shaughnessy DF, Hill AVS, Bowden DK, Weatherall DJ, Clegg JB: Globin genes in Micronesia: origins and affinities of Pacific Island peoples. Amer J Hum Genet. 1990, 46: 144-155.PubMedCentralPubMed
18.
Livingstone FB: Frequencies of Haemoglobin Variants. 1985, Oxford: Oxford University Press
19.
Valcindag E, Elguero E, Arnathau C, Durand P, Aklana J, Anderson TJ, Aubouy A, Balloux F, Besnard P, Bogreau H, Canevale P, D’Alessandro U, Fontenille D, Gamboa D, Jombart T, Le Mire J, Leroy E, Maestre A, Mayxay M, Menard , Musset L, Newton PN, Nkoghe D, Noya O, Ollomo B, Rogier , Veron V, Wide A, Zakeri S, Carme B, Legrand E, Chevillon C, Ayala FJ, Renaud F, Prugnolle F: Multiple independent introductions of Plasmodium falciparum in South America. Proc Nat Acad Sci USA. 2012, 109: 511-516. 10.1073/pnas.1119058109.CrossRef
20.
Siniscaloco M, Bernini L, Latte B, Motulsky AG: Favism and thalassemia in Sardinia and their relationship to malaria. Nature. 1961, 190: 1179-1180. 10.1038/1901179a0.CrossRef
21.
Flint J, Hill AV, Bowden DK, Oppenheimer SJ, Sill PR, Serjeantson SW, Bana-Koiri J, Bhatia K, Alpers MP, Boyce AJ, Weatherall DJ, Clegg JB: High frequencies of alpha-thalassemia are the result of natural selection by malaria. Nature. 1986, 321: 744-750. 10.1038/321744a0.CrossRefPubMed
22.
Hill AVS, Bowden DK, O’Shaughnessy DF, Weatherall DJ, Clegg JB: b-thalassemia in Melanesia: association with malaria and characterization of a common variant (IVS1 nt 5 G-C). Blood. 1988, 72: 9-14.PubMed
23.
Kwiatkowski DP, Luoni G: Malaria. Genetic Susceptibility to Infectious Diseases. Edited by: Kaslow RA, McNicholl JM, Hill AVS. 2008, Oxford: Oxford University Press, 372-386.
24.
Verra F, Mangang VD, Modiano D: Genetics of susceptibility to Plasmodium falciparum: from classical malaria resistance genes towards genome-wide association studies. Parasite Immun. 2009, 31: 234-253. 10.1111/j.1365-3024.2009.01106.x.CrossRef
25.
López C, Saravia C, Gomez A, Hoebeke J, Patarroyo MA: Mechanisms of genetically-based resistance to malaria. Gene. 2011, 467: 1-12.CrossRef
26.
Driss A, Hibbert JM, Wilson NO, Iqbal SA, Adamkiewicz TV, Stiles JK: Genetic polymorphisms linked to susceptibility to malaria. Malar J. 2011, 10: 271-10.1186/1475-2875-10-271.PubMedCentralCrossRefPubMed
27.
28.
Weatherall DJ: Genetic variation and susceptibility to infection: the red cell and malaria. Brit J Haemat. 2008, 141: 276-286. 10.1111/j.1365-2141.2008.07085.x.CrossRefPubMed
29.
Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E: The global prevalence of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis. Blood Cells Mol Dis. 2009, 42: 267-278. 10.1016/j.bcmd.2008.12.005.CrossRefPubMed
30.
Verrelli BC, Tishkoff SA, Stone AC, Touchman JW: Contrasting histories of G6PD molecular evolution and malarial resistance in humans and chimpanzees. Molec Biol Evol. 2006, 23: 1592-1601. 10.1093/molbev/msl024.CrossRefPubMed
31.
MacFie TS, Nerrienet E, Bontrop RE, Mundy NI: The action of falciparum malaria on the human and chimpanzee genomes compared: Absence of evidence for a genomic signature of malaria at HBB and G6PD in three subspecies of chimpanzee. Infect Genet Evol. 2009, 9: 1248-1252. 10.1016/j.meegid.2009.06.025.CrossRefPubMed
32.
Demogines A, Truong KA, Sawyer SL: Species-specific features of DARC, the primate receptor for Plasmodium vivax and Plasmodium knowlesi. Molec Biol Evol. 2011, 29: 445-449.PubMedCentralCrossRefPubMed
33.
Tung J, Primau A, Bouley AJ, Severson TF, Alberts SC, Wray GA: Evolution of a malaria resistance gene in wild primates. Nature. 2009, 460: 388-391.PubMed
34.
Currat M, Trabucher G, Rees D, Perrin P, Harding RM, Clegg JB, Langaney A, Excoffier L: Molecular analysis of the β-globin gene cluster in the Niokholo Mandenka population reveals a recent origin of the βS Senegal mutation. Amer J Hum Genet. 2002, 70: 207-223. 10.1086/338304.PubMedCentralCrossRefPubMed
35.
Ralph P, Coop G: Parallel adaptation: one or many waves of advance of an advantageous allele?. Genetics. 2010, 186: 647-668. 10.1534/genetics.110.119594.PubMedCentralCrossRefPubMed
36.
Wood ET, Stover DA, Slatkin M, Nachman MW, Hammer MF: The β-globin recombinational hotspot reduces the effects of strong selection around HbC, a recently arisen mutation providing resistance to malaria. Amer J Hum Genet. 2005, 77: 637-642. 10.1086/491748.PubMedCentralCrossRefPubMed
37.
Ohashi J, Naka I, Patarapotikul J, Hananantachai H, Brittenham , Looareesuwan S, Clark AG, Tokunaga K: Strong linkage disequilibrium of a HbE variant with the (AT)9(T)5 repeat in the BP1 binding site upstream of the β-globin gene in the Thai population. J Hum Genet. 2005, 50: 7-11. 10.1007/s10038-004-0210-z.PubMedCentralCrossRefPubMed
38.
Fucharoen G, Fucharoen S, Sanchaisuriya K, Sae-ung N, Suyasunanond U, Sriwilai , Chinorak P: Frequency distribution and haplotypic heterogeneity of βE-globin gene among eight minority groups of northeast Thailand. Hum Hered. 2002, 53: 18-22. 10.1159/000048600.CrossRefPubMed
39.
Ohashi J, Naka I, Patarapotikul J, Hananantachai H, Brittenham G, Looareesuwan S, Clark AG, Tokunaga K: Extended linkage disequilibrium surrounding the hemoglobin E variant due to malarial selection. Amer J Hum Genet. 2004, 74: 1198-1208. 10.1086/421330.PubMedCentralCrossRefPubMed
40.
Tishkoff SA, Varkonyl R, Cahinhinan N, Abbes S, Argyropoulos G, Destro-Bisol G, Drousiotou A, Dangerfield B, Lefranc G, Loiselet J, Piro A, Stoneking M, Tagarelli A, Tagarelli G, Touma EH, Williams SM, Clark AG: Haplotype diversity and linkage disequilibrium at human G6PD: recent origin of alleles that confer malarial resistance. Science. 2001, 293: 455-462. 10.1126/science.1061573.CrossRefPubMed
41.
Slatkin M: A Bayesian method for jointly estimating allele age and selection intensity. Genet Res. 2008, 90: 129-137.CrossRef
42.
Louicharoen C, Patin E, Paul R, Nuchprayoon I, Witoonpanich B, Peerapittayamongkol C, Casademont I, Sura T, Laird NM, Singhasivanon P, Quintana-Murci L, Sakuntabhai A: Positively selected G6PD-Mahidol mutation reduces Plasmodium vivax density in southeast Asian. Science. 2009, 326: 1546-1549. 10.1126/science.1178849.CrossRefPubMed
43.
Weatherall DJ, Clegg JB: The Thalassemia Syndromes. 2001, Oxford: Blackwell Scientific, 4CrossRef
44.
Jarolim P, Palek J, Amato D, Hassan K, Sapak P, Nurse GT, Rubin HL, Zhai S, Sahr KE, Liu S-C: Deletion in erythrocyte band 3 gene in malaria–resistant Southeast Asian ovalocytosis. Proc Nat Acad Sci USA. 1991, 88: 11022-11026. 10.1073/pnas.88.24.11022.PubMedCentralCrossRefPubMed
45.
Genton B, Al-Yaman F, Mgone CS, Alexander N, Paniu MM, Alpers MP: Ovalocytosis and cerebral malaria. Nature. 1995, 378: 564-565. 10.1038/378564a0.CrossRefPubMed
46.
Zimmerman PA: The enigma of Plasmodium vivax malaria and erythrocyte Duffy negativity. Infectious Disease and Host-Pathogen Evolution. Edited by: Dronamraju KR. 2004, Cambridge: Cambridge University Press, 141-172.CrossRef
47.
Mercereau-Puijalon O, Ménard D: Plasmodium vivax and the Duffy antigen: A paradigm revisited. Transfus Clin Biol. 2010, 17: 176-183. 10.1016/j.tracli.2010.06.005.CrossRefPubMed
48.
Miller LH, Mason SJ, Clyde DF, McGinnis MH: The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype FyFy. New England J Med. 1976, 295: 302-304. 10.1056/NEJM197608052950602.CrossRef
49.
Hamblin MT, Di Rienzo A: Detection of the signature of natural selection in humans: evidence from the Duffy blood group locus. Amer J Hum Genet. 2000, 66: 1669-1679. 10.1086/302879.PubMedCentralCrossRefPubMed
50.
Seixas S, Ferrand N, Rocha J: Microsatellite variation and evolution of the human Duffy blood group polymorphism. Molec Biol Evol. 2002, 19: 1802-1806. 10.1093/oxfordjournals.molbev.a004003.CrossRefPubMed
51.
Zimmerman PA, Woolley I, Masinde GL, Miller SM, McNamara D, Hazlett F, Mgone CS, Alpers MP, Genton B, Boatin BA, Kazure JW: Emergence of FY*null in a Plasmodium vivax-endemic region of Papua New Guinea. Proc Nat Acad Sci USA. 2009, 96: 13973-13977.CrossRef
52.
Hill AVS: HLA associations with malaria in Africa: some implications for MHC evolution. Molecular Evolution of the Major Histocompatibility Complex. Edited by: Klein J, Klein D. 1991, Berlin: Springer, 403-434.CrossRef
53.
Hedrick PW: Estimation of relative fitnesses from relative risk data and the predicted future of haemoglobin alleles S and C. J Evol Biol. 2004, 17: 221-224.CrossRefPubMed
54.
Hill AVS, Allsopp CEM, Kwiatkowski D, Anstey NM, Twumasi P, Rowe PA, Bennett S, Brewster D, McMichael AJ, Greenwood BM: Common west African HLA antigens are associated with protection from severe malaria. Nature. 1991, 352: 595-600. 10.1038/352595a0.CrossRefPubMed
55.
WHO: Demographic data for health situation assessment and projections. 1998, Geneva: WHO HST/HSP
56.
Modiano D, Luoni G, Sirima BS, Simpore J, Verra F, Konate A, Rashtrelli , Oliveri A, Calissano C, Paganotti GM, D’Urbano L, Sanou I, Sawadogo A, Modiano G, Coluzzi M: Haemoglobin C protects against clinical Plasmodium falciparum malaria. Nature. 2001, 414: 305-308. 10.1038/35104556.CrossRefPubMed
57.
Modiano D, Bancone G, Ciminelli BM, Pompei F, Blot I: Haemoglobin S and haemoglobin C: ‘quick but costly’ versus ‘slow but gratis’ genetic adaptations to Plasmodium falciparum malaria. Hum Molec Genet. 2008, 17: 789-799.CrossRefPubMed
58.
Agarwal A, Guindo A, Cissoko Y, Taylor TG, Coulibaly D, Kone A, Kayentao K, Djimde A, Plowe CV, Documbo O, Wellems TE, Diallo D: Hemoglobin C associated with protection from severe malaria in the Dogon of Mali, a West African population with a low prevalence of hemoglobin S. Blood. 2000, 96: 2358-2363.PubMed
59.
Williams TN, Mwangi TW, Wambua S, Peto TEA, Weatherall DJ: Negative epistasis between the malaria-protective effects of α+-thalassemia and the sickle cell trait. Nat Genet. 2005, 37: 1253-1262. 10.1038/ng1660.PubMedCentralCrossRefPubMed
60.
May J, Evans JA, Timmann C, Ehmen C, Busch W, Thye T, Agbenyega T, Horstmann RD: Hemoglobin variants and disease manifestations in severe falciparum malaria. J Amer Med Assoc. 2007, 297: 2220-2226. 10.1001/jama.297.20.2220.CrossRef
61.
Penman BS, Pybus OG, Weatherall DJ, Gupta S: Epistatic interactions between genetic disorders of hemoglobin can explain why the sickle-cell gene is uncommon in the Mediterranean. Proc Nat Acad Sci USA. 2009, 106: 21242-21246. 10.1073/pnas.0910840106.PubMedCentralCrossRefPubMed
62.
Penman BS, Habib S, Kanchan K, Gupta S: Negative epistasis between a+ thalassaemia and sickle cell trait can explain interpopulation variation in south Asia. Evolution. 2011, 65: 3625-3632. 10.1111/j.1558-5646.2011.01408.x.PubMedCentralCrossRefPubMed
63.
Hedrick PW: Genetics of Populations. 2011, Boston: Jones and Bartlett, 4
Metadata
Title
Resistance to malaria in humans: the impact of strong, recent selection
Author
Philip W Hedrick
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2012
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-11-349

Other articles of this Issue 1/2012

Malaria Journal 1/2012 Go to the issue

Research

Anti-plasmodial and insecticidal activities of the essential oils of aromatic plants growing in the Mediterranean area

Methodology

Laser-induced inactivation of Plasmodium falciparum

Research

Entomologic investigation of Plasmodium knowlesi vectors in Kuala Lipis, Pahang, Malaysia

Research

The magnitude and trend of artemether-lumefantrine stock-outs at public health facilities in Kenya

Research

Morbidity and mortality due to malaria in Est Mono district, Togo, from 2005 to 2010: a times series analysis

Research

Existence of the rdl mutant alleles among the anopheles malaria vector in Indonesia
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits